Showing 13,381 - 13,400 results of 13,836 for search '"On the Media"', query time: 0.09s Refine Results
  1. 13381
  2. 13382

    Special issue: Proceedings of the 15th ISIC - The Information Behaviour Conference, Aalborg, Denmark, August 26-29, 2024

    Published 2024-06-01
    “…Day Health information post-encountering behaviours on social media platforms Khalid U Fallatah, Morgan A Harvey, Sophie Rutter Information seeking behaviour in music conductors’ repertoire selection Christina Firkins, Michael Barrett-Berg, Ina Fourie Models and theories that can guide grief and bereavement information interventions: an information behaviour lens Ina Fourie Case study on a scientific oral history project using information practice analysis Deborah A. …”
    Get full text
    Article
  3. 13383
  4. 13384

    Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccha... by Tao Chen, Duolao Wang, Konstantinos Liatsikos, Stephen B Gordon, Hassan Burhan, Ben Morton, Tinashe K Nyazika, Bradford D Gessner, Helen Hill, Andrea Collins, Josh Hamilton, Kelly Davies, Fred Fyles, Phoebe Hazenberg, Elizabeth Begier, Angela Hyder-Wright, Sherin Pojar, Christopher Myerscough, Jesus Reine, Ryan E Robinson, Britta Urban, Elena Mitsi, Carla Solorzano, Angela Quinn, Kaijie Pan, Annaliesa S Anderson, Christian Theilacker, Daniela M Ferreira, Kelly Convey, James Court, Madlen Farrar, Lisa Hitchins, Ashleigh Howard, Lauren Kerruish, Samuel Latham, Annabel Murphy, Elissavet Nikolaou, Angelina Peterson

    Published 2022-07-01
    “…Introduction Despite widely available vaccinations, Streptococcus pneumoniae (SPN) remains a major cause of morbidity and mortality worldwide, causing community-acquired pneumonia, meningitis, otitis media, sinusitis and bacteraemia. Here, we summarise an ethically approved protocol for a double-blind, randomised controlled trial investigating the effect of the 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPV23) on pneumococcal nasopharyngeal colonisation acquisition, density and duration using experimental human pneumococcal challenge (EHPC).Methods and analysis Healthy adult participants aged 18–50 years will be randomised to receive PCV13, PPV23 or placebo and then undergo one or two EHPCs involving intranasal administration of SPN at 1-month post-vaccination with serotype 3 (SPN3) and 6 months with serotype 6B (SPN6B). …”
    Get full text
    Article
  5. 13385
  6. 13386
  7. 13387
  8. 13388
  9. 13389
  10. 13390
  11. 13391
  12. 13392
  13. 13393
  14. 13394
  15. 13395
  16. 13396
  17. 13397
  18. 13398
  19. 13399
  20. 13400